TAP Consulting’s DexCom DXCM Stock Holding History

TAP Consulting’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$243K	Hold	3,125	–	–	0.05%	141
2024 Q3	$210K	Hold	3,125	–	–	0.04%	151
2024 Q2	$354K	Hold	3,125	–	–	0.07%	131
2024 Q1	$433K	Hold	3,125	–	–	0.1%	123
2023 Q4	$388K	Hold	3,125	–	–	0.09%	108
2023 Q3	$292K	Sell	3,125 -75	-2%	-$8.45K	0.08%	117
2023 Q2	$411K	Hold	3,200	–	–	0.1%	114
2023 Q1	$372K	Hold	3,200	–	–	0.09%	113
2022 Q4	$362K	Hold	3,200	–	–	0.09%	108
2022 Q3	$258K	Hold	3,200	–	–	0.07%	116
2022 Q2	$238K	Hold	3,200	–	–	0.07%	109
2022 Q1	$409K	Hold	3,200	–	–	0.11%	104
2021 Q4	$430K	Hold	3,200	–	–	0.1%	107
2021 Q3	$437K	Hold	3,200	–	–	0.12%	104
2021 Q2	$342K	Hold	3,200	–	–	0.1%	107
2021 Q1	$288K	Hold	3,200	–	–	0.09%	112
2020 Q4	$296K	Hold	3,200	–	–	0.11%	110
2020 Q3	$330K	Sell	3,200 -20	-0.6%	-$2.09K	0.13%	101
2020 Q2	$326K	Buy	3,220 +20	+0.6%	+$1.79K	0.16%	90
2020 Q1	$215K	Buy	+3,200	New	+$199K	0.14%	102

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

TAP Consulting's DXCM Position: Q4 2024 in Review

TAP Consulting held its DexCom (DXCM) position steady in Q4 2024 at 3,125 shares worth $243K. The position accounts for 0.05% of the portfolio, ranked #141.

TAP Consulting first reported a position in DXCM in Q1 2020 and has held it in 20 quarters since. The position peaked at $437K in Q3 2021. 952 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

TAP Consulting held 3,125 shares of DexCom worth $243K as of Q4 2024.
TAP Consulting left its DexCom share count unchanged in Q4 2024.
DexCom made up 0.05% of TAP Consulting's portfolio in Q4 2024, its #141 holding.
TAP Consulting first reported a position in DexCom in Q1 2020 and has held it in 20 quarters since.
TAP Consulting's DexCom position peaked at $437K in Q3 2021.
952 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on TAP Consulting's 13F filing for Q4 2024, filed 11 Feb 2025.